title: Safety and efficacy of sitagliptin-metformin in fixed combination for the treatment of type 2 diabetes mellitus.
abstract: The biguanide, metformin, is considered first-line treatment for type 2 diabetes. Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor acts through the incretin pathway and has a glucose dependent mode of action. The complementary hypoglycemic properties of these drugs make fixed dose combination treatment an attractive prospect. Evidence from recent clinical trials suggests a beneficial effect of the combination on efficacy, demonstrated by significant improvement of hemoglobin A1c (HbA1c), fasting and postprandial glucose levels. The fixed dose combination is likely to have greater patient tolerability compared with monotherapy with either agent because of low rates of hypoglycemia, weight neutrality, and lower rates of side effects. High acquisition cost and paucity of long-term safety data are, however, potential barriers to their wider use. An overview of the pharmacology and clinical outcomes from recent trials of the metformin-sitagliptin combination and how the combination could fit into the type 2 diabetes treatment algorithm is presented in this review.
authors.affiliation: Oxford Centre for Diabetes Endocrinology and Metabolism and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
authors.forename: Chitrabhanu
authors.initials: C
authors.lastname: Ballav
authors.forename: Stephen C L
authors.initials: SC
authors.lastname: Gough
keywords: DPP-4 inhibitors; incretin-based therapies; metformin; sitagliptin; type 2 diabetes
references.citation: JAMA Intern Med. 2013 Apr 8;173(7):534-9
references.pmid: 23440284
references.citation: Diabetes Obes Metab. 2010 May;12(5):442-51
references.pmid: 20415693
references.citation: Diabetes Metab Res Rev. 2010 Oct;26(7):540-9
references.pmid: 20824678
references.citation: J Clin Endocrinol Metab. 2002 Mar;87(3):1239-46
references.pmid: 11889194
references.citation: Diabetes Obes Metab. 2007 Sep;9(5):733-45
references.pmid: 17593236
references.citation: Diabetes Care. 2001 Mar;24(3):489-94
references.pmid: 11289473
references.citation: BMJ. 2011 Mar 17;342:d1309
references.pmid: 21415101
references.citation: J Clin Endocrinol Metab. 2001 Aug;86(8):3853-60
references.pmid: 11502823
references.citation: Diabetologia. 1986 Jan;29(1):46-52
references.pmid: 3514343
references.citation: Diabetes. 2008 Mar;57(3):678-87
references.pmid: 18057091
references.citation: JAMA. 2002 Jan 16;287(3):360-72
references.pmid: 11790216
references.citation: Diabetes Care. 2007 Aug;30(8):1979-87
references.pmid: 17485570
references.citation: Endocrinol Metab Clin North Am. 2005 Mar;34(1):77-98
references.pmid: 15752923
references.citation: Diabetes Care. 2013 Jul;36(7):2118-25
references.pmid: 23645885
references.citation: Diabetes Obes Metab. 2011 Jul;13(7):644-52
references.pmid: 21410627
references.citation: Nat Clin Pract Endocrinol Metab. 2007 Jan;3(1):4-5
references.pmid: 17179922
references.citation: Diabetes Care. 2003 Jan;26(1):252
references.pmid: 12502699
references.citation: Diabetes Obes Metab. 2008 Sep;10(10):959-69
references.pmid: 18201203
references.citation: Diabetes Care. 2013 Jul;36(7):2126-32
references.pmid: 23645884
references.citation: Curr Med Res Opin. 2009 Oct;25(10):2507-14
references.pmid: 19691426
references.citation: Nature. 2001 Dec 13;414(6865):782-7
references.pmid: 11742409
references.citation: Diabetes Care. 2006 Dec;29(12):2638-43
references.pmid: 17130197
references.citation: Diabetes Care. 2009 Jan;32(1):193-203
references.pmid: 18945920
references.citation: Diabetes Obes Metab. 2008 Jun;10(6):506-13
references.pmid: 18284437
references.citation: Ann Intern Med. 1999 Aug 17;131(4):281-303
references.pmid: 10454950
references.citation: Diabetes Care. 2011 Jan;34 Suppl 1:S4-10
references.pmid: 21193627
references.citation: Diabetologia. 2011 Dec;54(12):3101-10
references.pmid: 21947382
references.citation: N Engl J Med. 2006 Dec 7;355(23):2427-43
references.pmid: 17145742
references.citation: Endocrinology. 1999 Nov;140(11):5356-63
references.pmid: 10537167
references.citation: Diabetes Obes Metab. 2007 Mar;9(2):194-205
references.pmid: 17300595
references.citation: Int J Clin Pract. 2011 Sep;65(9):930-8
references.pmid: 21849007
references.citation: Clin Drug Investig. 2010;30(12):855-66
references.pmid: 20923244
references.citation: Lancet. 1998 Sep 12;352(9131):837-53
references.pmid: 9742976
references.citation: Clin Pharmacol Ther. 2007 May;81(5):761-7
references.pmid: 17392725
references.citation: Diabetologia. 1993 Aug;36(8):741-4
references.pmid: 8405741
references.citation: Clin Pharmacol Ther. 2005 Dec;78(6):675-88
references.pmid: 16338283
references.citation: Diabetes. 2013 Jul;62(7):2178-80
references.pmid: 23596147
references.citation: J Clin Endocrinol Metab. 2009 Jun;94(6):1843-52
references.pmid: 19336511
references.citation: Curr Med Res Opin. 2009 Mar;25(3):569-83
references.pmid: 19232032
references.citation: Biopharm Drug Dispos. 2007 Sep;28(6):315-22
references.pmid: 17575559
references.citation: Am J Physiol. 1996 Sep;271(3 Pt 1):E458-64
references.pmid: 8843738
references.citation: Biochem Biophys Res Commun. 2002 Nov 15;298(5):779-84
references.pmid: 12419322
references.citation: Curr Med Res Opin. 2008 Feb;24(2):537-50
references.pmid: 18194595
references.citation: Eur J Biochem. 1993 Jun 15;214(3):829-35
references.pmid: 8100523
references.citation: Br J Clin Pharmacol. 1987 May;23(5):545-51
references.pmid: 3593625
references.citation: Clin Pharmacokinet. 1996 May;30(5):359-71
references.pmid: 8743335
references.citation: Clin Ther. 2002 Mar;24(3):460-7
references.pmid: 11952029
references.citation: Diabetes Care. 2012 Jun;35(6):1364-79
references.pmid: 22517736
references.citation: Am J Health Syst Pharm. 1997 Apr 15;54(8):893-903
references.pmid: 9114921
references.citation: J Clin Endocrinol Metab. 2003 Mar;88(3):1323-32
references.pmid: 12629126
references.citation: Diabetes Obes Metab. 2012 May;14(5):409-18
references.pmid: 22059736
references.citation: Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006739
references.pmid: 18425967
references.citation: Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E1010-8
references.pmid: 10827002
references.citation: Diabetes Obes Metab. 2003 Nov;5(6):424-31
references.pmid: 14617228
references.citation: Curr Med Res Opin. 2006 Oct;22(10):1939-47
references.pmid: 17022853
references.citation: J Clin Endocrinol Metab. 2008 Oct;93(10):3703-16
references.pmid: 18628530
references.citation: Lancet. 2010 Aug 7;376(9739):431-9
references.pmid: 20580422
references.citation: Horm Metab Res. 2002 Mar;34(3):150-4
references.pmid: 11972305
references.citation: Diabetes Care. 2005 Sep;28(9):2093-9
references.pmid: 16123472
references.citation: Diabetologia. 2011 Jan;54(1):10-8
references.pmid: 20871975
references.citation: J Biol Chem. 2000 Jan 7;275(1):223-8
references.pmid: 10617608